Sign Up Today and Learn More About Capital Rx Stock
Invest in or calculate the value of your shares in Capital Rx or other pre-IPO companies through EquityZen's platform.
Capital Rx Stock (CAIR)
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
About Capital Rx Stock
Founded
2017
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Capital Rx Press Mentions
Stay in the know about the latest news on Capital Rx
Capital Rx Ranks No. 18 on Inc.'s 2025 List of the Fastest-Growing Private Companies in the Northeast
prnewswire • Apr 01, 2025
Capital Rx Unveils Healthcare's First Unified Pharmacy and Medical Claims Processing Platform
prnewswire • Feb 10, 2025
Pharmacy benefit management unicorn Capital Rx rakes in $3.5 billion in revenue as Congress targets drug middlemen
businessinsider • Feb 10, 2025
Capital Rx Inducted into the Inaugural Hall of Fame by Digital Health New York (DHNY)
prnewswire • Feb 06, 2025
Capital Rx Ranks No. 411 on the 2024 Inc. 5000, Making the List of America's Fastest-Growing Private Companies for the Third Year
prnewswire • Jan 10, 2025
Capital Rx Management
Leadership team at Capital Rx
CEO & Co-Founder
AJ Loiacono
COO & Co-Founder
Joseph Alexander
Join now and verify your accreditation status to gain access to:
- Capital Rx Current Valuation
- Capital Rx Stock Price
- Capital Rx Management
- Available deals in Capital Rx and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Capital Rx Cap Table and Funding History by Share Class and Liquidity Preferences
- Capital Rx Revenue and Financials
- Capital Rx Highlights
- Capital Rx Business Model
- Capital Rx Risk Factors
- Capital Rx Research Report from SACRA Research
Trading Capital Rx Stock
How to invest in Capital Rx stock?
Accredited investors can buy pre-IPO stock in companies like Capital Rx through EquityZen funds. These investments are made available by existing Capital Rx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Capital Rx stock?
Shareholders can sell their Capital Rx stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
